The 2026 BPD Singapore Biopharmaceutical Process Development Summit concluded successfully on September 22–23 at the Marina Bay Sands Expo & Convention Centre in Singapore
The summit brought together more than 60 speakers and over 600 attendees. Drawing on Singapore’s strategic location, the event featured a wide range of formats, including thematic forums, closed-door meetings, exhibition-area interactions, BPD Match buyer–supplier meetings, and business networking activities.
The summit focused on bioprocess innovation and development in Southeast Asia, manufacturing capacity partnerships, market access, and regional regulatory compliance. It built a bridge for collaboration among Chinese pharmaceutical companies, suppliers, and Southeast Asian pharmaceutical companies, while enabling in-depth discussions on the internationalization of bioprocess development and manufacturing in a globalized landscape.
Milestone Pharma showcased at Booth S11 its integrated process development and quality characterization solutions for biologics.
Milestone Pharma provides complete characterization studies that can be used directly for global regulatory submissions, helping clients confidently address regulatory reviews across different countries.
As a specialized pharmaceutical CRO, Milestone Pharma drew on its comprehensive capabilities in biologics structural and quality characterization to engage in face-to-face exchanges with industry peers from China and abroad.
Together, they explored new opportunities for bringing Chinese biologics to international markets and for commercialization partnerships in Southeast Asia.
Focusing on Global Biopharmaceutical Development and Expanding International Markets Together
To meet the needs of global biopharmaceutical R&D and commercialization, Milestone Pharma will continue to enhance its biologics analytical and quality research capabilities and provide clients with professional technical support spanning R&D, process development, quality characterization, and global regulatory submissions.
Through professional, efficient, and internationally oriented services, Milestone Pharma will continue to help more biopharmaceutical companies advance their global R&D and commercialization, providing reliable quality research and technical support for Chinese biologics entering international markets.
